Clinical trialNCT00906529WithdrawnPhase 4Interventional

Aggressive Versus Conservative Blood Glucose Control in Hospitalized Type 2 Diabetic Patients Using Detemir and Aspart Insulin

SponsorUniversity of Texas Southwestern Medical CenterEnrollment0Type 2 Diabetes

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to determine whether aggressive (goal pre-prandial blood glucose \<110 mg/dl) versus conservative (goal pre-prandial blood glucose \<180mg/dl) diabetes treatment of type 2 diabetic patients on the general medical wards has any effect on hospital outcomes.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

John Richard, MD
University of Texas Southwestern Medical Center
Study Director
clinicaltrials.gov ↗
Philip Raskin, MD
University of Texas Southwestern Medical Center
Study ChairKOL profile →
clinicaltrials.gov ↗
Steve Fordan, MD
University of Texas Southwestern Medical Center
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Parkland Memorial Hospital
Dallas, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Levemir and Novolog Insulin

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 May 2009
Primary completion: 31 Dec 2010
Completion: 31 Mar 2011
Last update posted: 16 Jan 2019
Registered enrollment: 0
Registry id: NCT00906529

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.